BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 16104877)

  • 1. Etodolac inhibits EBER expression and induces Bcl-2-regulated apoptosis in Burkitt's lymphoma cells.
    Kobayashi M; Nakamura S; Shibata K; Sahara N; Shigeno K; Shinjo K; Naito K; Ohnishi K
    Eur J Haematol; 2005 Sep; 75(3):212-20. PubMed ID: 16104877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Etodolac induces apoptosis and inhibits cell adhesion to bone marrow stromal cells in human myeloma cells.
    Nakamura S; Kobayashi M; Shibata K; Sahara N; Shigeno K; Shinjo K; Naito K; Hayashi H; Ohnishi K
    Leuk Res; 2006 Feb; 30(2):123-35. PubMed ID: 16046235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COX inhibitors modulate bFGF-induced cell survival in MCF-7 breast cancer cells.
    Teh SH; Hill AK; Foley DA; McDermott EW; O'Higgins NJ; Young LS
    J Cell Biochem; 2004 Mar; 91(4):796-807. PubMed ID: 14991771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The cloning of human Smac gene and its pro-apoptotic effect on Burkitt's lymphoma cells].
    Lu C; Wu SH; Chen JQ; Zhao F; Chi X; Pan XQ; Fei L; Guo M; Huang SM; Guo XR; Chen RH
    Zhonghua Er Ke Za Zhi; 2005 Jul; 43(7):503-6. PubMed ID: 16083549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proapoptotic and antiproliferative potential of selective cyclooxygenase-2 inhibitors in human liver tumor cells.
    Kern MA; Schubert D; Sahi D; Schöneweiss MM; Moll I; Haugg AM; Dienes HP; Breuhahn K; Schirmacher P
    Hepatology; 2002 Oct; 36(4 Pt 1):885-94. PubMed ID: 12297835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific COX-2 inhibitor, meloxicam, suppresses proliferation and induces apoptosis in human HepG2 hepatocellular carcinoma cells.
    Li J; Chen X; Dong X; Xu Z; Jiang H; Sun X
    J Gastroenterol Hepatol; 2006 Dec; 21(12):1814-20. PubMed ID: 17074019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indole-3-carbinol induces cMYC and IAP-family downmodulation and promotes apoptosis of Epstein-Barr virus (EBV)-positive but not of EBV-negative Burkitt's lymphoma cell lines.
    Perez-Chacon G; de Los Rios C; Zapata JM
    Pharmacol Res; 2014 Nov; 89():46-56. PubMed ID: 25180456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth inhibition and apoptosis of human B-cell lymphoma in vitro and in vivo by Bcl-2 short hairpin RNA.
    Liu Y; Shen Y; Qin C; Shi Y; Rong G; Yu X
    Oncol Rep; 2013 Jan; 29(1):244-52. PubMed ID: 23076380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of cyclooxygenase-2 in uterine endometrial cancer and anti-tumor effects of a selective COX-2 inhibitor.
    Hasegawa K; Ohashi Y; Ishikawa K; Yasue A; Kato R; Achiwa Y; Nishio E; Udagawa Y
    Int J Oncol; 2005 May; 26(5):1419-28. PubMed ID: 15809736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclooxygenase-2 overexpression reduces apoptotic susceptibility by inhibiting the cytochrome c-dependent apoptotic pathway in human colon cancer cells.
    Sun Y; Tang XM; Half E; Kuo MT; Sinicrope FA
    Cancer Res; 2002 Nov; 62(21):6323-8. PubMed ID: 12414664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydrogen peroxide in the Burkitt's lymphoma cell line Raji provides protection against arsenic trioxide-induced apoptosis via the phosphoinositide-3 kinase signalling pathway.
    Lu D; Bai XC; Gui L; Su YC; Deng F; Liu B; Li XM; Zeng WS; Cheng BL; Luo SQ
    Br J Haematol; 2004 May; 125(4):512-20. PubMed ID: 15142122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD95-mediated apoptosis in Burkitt's lymphoma B-cells is associated with Pim-1 down-regulation.
    Matou-Nasri S; Rabhan Z; Al-Baijan H; Al-Eidi H; Yahya WB; Al Abdulrahman A; Almobadel N; Alsubeai M; Al Ghamdi S; Alaskar A; AlBalwi M; Alzahrani M; Alabdulkareem I
    Biochim Biophys Acta Mol Basis Dis; 2017 Jan; 1863(1):239-252. PubMed ID: 27641442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of apoptosis by Chan Su, a traditional Chinese medicine, in human bladder carcinoma T24 cells.
    Ko WS; Park TY; Park C; Kim YH; Yoon HJ; Lee SY; Hong SH; Choi BT; Lee YT; Choi YH
    Oncol Rep; 2005 Aug; 14(2):475-80. PubMed ID: 16012733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific COX-2 inhibitor NS398 induces apoptosis in human liver cancer cell line HepG2 through BCL-2.
    Huang DS; Shen KZ; Wei JF; Liang TB; Zheng SS; Xie HY
    World J Gastroenterol; 2005 Jan; 11(2):204-7. PubMed ID: 15633216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of cyclooxygenase-1 and -2 expression by targeting the endothelin a receptor in human ovarian carcinoma cells.
    Spinella F; Rosanò L; Di Castro V; Nicotra MR; Natali PG; Bagnato A
    Clin Cancer Res; 2004 Jul; 10(14):4670-9. PubMed ID: 15269139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meloxicam inhibits osteosarcoma growth, invasiveness and metastasis by COX-2-dependent and independent routes.
    Naruse T; Nishida Y; Hosono K; Ishiguro N
    Carcinogenesis; 2006 Mar; 27(3):584-92. PubMed ID: 16219634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Akt regulates COX-2 mRNA and protein expression in mutated-PTEN human endometrial cancer cells.
    St-Germain ME; Gagnon V; Mathieu I; Parent S; Asselin E
    Int J Oncol; 2004 May; 24(5):1311-24. PubMed ID: 15067356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of cyclooxygenase-2 and activation of peroxisome proliferator-activated receptor-gamma synergistically induces apoptosis and inhibits growth of human breast cancer cells.
    Michael MS; Badr MZ; Badawi AF
    Int J Mol Med; 2003 Jun; 11(6):733-6. PubMed ID: 12736714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of selective COX-2 inhibitors as therapeutic agents against canine mammary tumors.
    Saito T; Tamura D; Asano R
    Oncol Rep; 2014 Apr; 31(4):1637-44. PubMed ID: 24503782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Etodolac, a selective cyclooxygenase-2 inhibitor, induces upregulation of E-cadherin and has antitumor effect on human bladder cancer cells in vitro and in vivo.
    Okamoto A; Shirakawa T; Bito T; Shigemura K; Hamada K; Gotoh A; Fujisawa M; Kawabata M
    Urology; 2008 Jan; 71(1):156-60. PubMed ID: 18242386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.